Validation pour Ingenuity182

vers la météo de la validation par utilisateur

Ingenuity182

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 61 - PMID ?

In activated T lymphocytes from SP peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti NODE protein antibody .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                                                  +---------------------------SUBJ:V-N---------------------------+                      
                     +---------COMP:N-N(from)--------+                  +-------------------OBJ:V-N------------------+                 |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+                 |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                +COMP:V-N(b+      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
COMP:V-N(In) (__NODE__,lymphocyte)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 1

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                               +----------------------------------COMP:V-N(from)---------------------------------+                      
                     |                               |                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                               |                  +-------------------OBJ:V-N------------------+                 |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+                 |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                +COMP:V-N(b+      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
COMP:V-N(In) (__NODE__,lymphocyte)
COMP:V-N(from) (__NODE__,blood)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 2

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                                                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                                                  +-------------------OBJ:V-N------------------+                 |                      
                     +---------COMP:N-N(from)--------+                  |            +------------SUBJ:V-N-----------+                 |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +---------SUBJ:V-N--------+     |                 |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+          |     +COMP:V-N(b+      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
COMP:V-N(In) (__NODE__,lymphocyte)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 3

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                                                  +---------------------------SUBJ:V-N---------------------------+                      
                     +---------COMP:N-N(from)--------+                  +-------------------OBJ:V-N------------------+                 |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+                 |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                +COMP:V-N(b+      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
COMP:V-N(In) (__NODE__,lymphocyte)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 4

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                               +----------------------------------COMP:V-N(from)---------------------------------+                      
                     |                               |                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                               |                  +-------------------OBJ:V-N------------------+                 |                      
                     |                               |                  |            +------------SUBJ:V-N-----------+                 |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +---------SUBJ:V-N--------+     |                 |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+          |     +COMP:V-N(b+      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
COMP:V-N(In) (__NODE__,lymphocyte)
COMP:V-N(from) (__NODE__,blood)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 5

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                               +----------------------------------COMP:V-N(from)---------------------------------+                      
                     |                               |                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                               |                  +-------------------OBJ:V-N------------------+                 |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+                 |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                +COMP:V-N(b+      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
COMP:V-N(In) (__NODE__,lymphocyte)
COMP:V-N(from) (__NODE__,blood)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 6

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 7

                     +-------------------COMP:V-N(In)-------------------+                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 8

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  +-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 9

                     +-------------------COMP:V-N(In)-------------------+-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 10

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 11

                     +-------------------COMP:V-N(In)-------------------+                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 12

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  +-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 13

                     +-------------------COMP:V-N(In)-------------------+-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 14

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+                               +-------COMP:V-N(by)------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 15

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+                               |                                        
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---------OBJ:V-N---------+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                +COMP:V-N(b+      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 16

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+                               +---------OBJ:V-N---------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---COMP:V-N(by)--+       |              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          +MOD_AT+       |              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,__NODE__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__NODE__,anti)

Analyse 17

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+                               +-------COMP:V-N(by)------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 18

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+                               |                                        
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---------OBJ:V-N---------+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                +COMP:V-N(b+      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 19

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+------------SUBJ:V-N-----------+-------COMP:V-N(by)------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 20

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+                               +-------COMP:V-N(by)------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 21

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+------------SUBJ:V-N-----------+                                        
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+---------SUBJ:V-N--------+     +---------OBJ:V-N---------+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+          |     +COMP:V-N(b+      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 22

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+                               |                                        
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---------OBJ:V-N---------+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                +COMP:V-N(b+      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 23

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+                               +---------OBJ:V-N---------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---COMP:V-N(by)--+       |              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          +MOD_AT+       |              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,__NODE__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__NODE__,anti)

Analyse 24

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+------------SUBJ:V-N-----------+---------OBJ:V-N---------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+---------SUBJ:V-N--------+     +---COMP:V-N(by)--+       |              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+          |     |          +MOD_AT+       |              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,__NODE__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__NODE__,anti)

Analyse 25

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     +---------COMP:N-N(from)--------+       +-----MOD_ATT:N-ADJ-----+                               +---------OBJ:V-N---------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---COMP:V-N(by)--+       |              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          +MOD_AT+       |              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,__NODE__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__NODE__,anti)

Analyse 26

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+------------SUBJ:V-N-----------+-------COMP:V-N(by)------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 27

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+                               +-------COMP:V-N(by)------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 28

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+------------SUBJ:V-N-----------+                                        
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+---------SUBJ:V-N--------+     +---------OBJ:V-N---------+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+          |     +COMP:V-N(b+      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 29

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+                               |                                        
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---------OBJ:V-N---------+              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                +COMP:V-N(b+      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 30

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+------------SUBJ:V-N-----------+---------OBJ:V-N---------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+---------SUBJ:V-N--------+     +---COMP:V-N(by)--+       |              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+          |     |          +MOD_AT+       |              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,__NODE__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__NODE__,anti)

Analyse 31

                     +------------------------------------------COMP:V-N(In)-----------------------------------------+                                        
                     |                               +-------------------------COMP:V-N(from)------------------------+                                        
                     |                               |       +-----MOD_ATT:N-ADJ-----+                               +---------OBJ:V-N---------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       |   +----MOD_ATT:N-N----+------------SUBJ:V-N-----------+---COMP:V-N(by)--+       |              
        |     +MOD_AT+              |        +MOD_ATT+       |   |      +-MOD_ATT:N-N+-COMP:N-N(of)-+                |          +MOD_AT+       |              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (disintegration,zVAD)
MOD_ATT:N-N (disintegration,FMK)
MOD_ATT:N-N (disintegration,decrease)
COMP:N-N(of) (disintegration,nucleolus)
COMP:V-N(In) (increase,lymphocyte)
COMP:V-N(from) (increase,blood)
SUBJ:V-N (increase,disintegration)
COMP:V-N(by) (increase,__NODE__)
OBJ:V-N (increase,protein)
MOD_ATT:N-N (__NODE__,anti)

Analyse 32

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                                                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                                                  +----------------------COMP:N-N(by)---------------------+      |                      
                     +---------COMP:N-N(from)--------+                  +-------------------OBJ:V-N------------------+          |      |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+          |      |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                |          |      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(In) (__NODE__,lymphocyte)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 33

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                               +----------------------------------COMP:V-N(from)---------------------------------+                      
                     |                               |                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                               |                  +----------------------COMP:N-N(by)---------------------+      |                      
                     |                               |                  +-------------------OBJ:V-N------------------+          |      |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+          |      |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                |          |      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(In) (__NODE__,lymphocyte)
COMP:V-N(from) (__NODE__,blood)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 34

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                                                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                                                  +----------------------COMP:N-N(by)---------------------+      |                      
                     |                                                  +-------------------OBJ:V-N------------------+          |      |                      
                     +---------COMP:N-N(from)--------+                  |            +------------SUBJ:V-N-----------+          |      |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +---------SUBJ:V-N--------+     |          |      |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+          |     |          |      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(In) (__NODE__,lymphocyte)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 35

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                                                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                                                  +----------------------COMP:N-N(by)---------------------+      |                      
                     +---------COMP:N-N(from)--------+                  +-------------------OBJ:V-N------------------+          |      |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+          |      |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                |          |      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(In) (__NODE__,lymphocyte)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 36

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                               +----------------------------------COMP:V-N(from)---------------------------------+                      
                     |                               |                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                               |                  +----------------------COMP:N-N(by)---------------------+      |                      
                     |                               |                  +-------------------OBJ:V-N------------------+          |      |                      
                     |                               |                  |            +------------SUBJ:V-N-----------+          |      |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +---------SUBJ:V-N--------+     |          |      |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+          |     |          |      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(In) (__NODE__,lymphocyte)
COMP:V-N(from) (__NODE__,blood)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 37

                     +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                      
                     |                               +----------------------------------COMP:V-N(from)---------------------------------+                      
                     |                               |                  +---------------------------SUBJ:V-N---------------------------+                      
                     |                               |                  +----------------------COMP:N-N(by)---------------------+      |                      
                     |                               |                  +-------------------OBJ:V-N------------------+          |      |                      
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+       +MOD_ATT:N-+            +------------SUBJ:V-N-----------+          |      |                      
        |     +MOD_AT+              |        +MOD_ATT+       |   +MOD_AT+            +-COMP:N-N(of)-+                |          |      +OBJ:V-N+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (decrease,zVAD)
MOD_ATT:N-N (decrease,FMK)
COMP:N-N(by) (decrease,anti)
COMP:N-N(of) (disintegration,nucleolus)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,disintegration)
COMP:V-N(In) (__NODE__,lymphocyte)
COMP:V-N(from) (__NODE__,blood)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 38

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 39

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 40

                     +-------------------COMP:V-N(In)-------------------+            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 41

                     +-------------------COMP:V-N(In)-------------------+            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 42

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |                                            |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,nucleolus)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 43

                     +-------------------COMP:V-N(In)-------------------+                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+                                            |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,nucleolus)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 44

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |            +---------SUBJ:V_PASS-N---------+----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 45

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 46

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  +-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |                                                       +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,nucleolus)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 47

                     +-------------------COMP:V-N(In)-------------------+            +---------SUBJ:V_PASS-N---------+----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 48

                     +-------------------COMP:V-N(In)-------------------+                                            +----COMP:V_PASS-N(by)----+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
COMP:V_PASS-N(by) (increase,protein)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 49

                     +-------------------COMP:V-N(In)-------------------+-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+                                                       +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,nucleolus)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 50

                     +-------------------COMP:V-N(In)-------------------+-----------------------------COMP:V-N(by)-----------------------------+              
                     +---------COMP:N-N(from)--------+                  |            +---------SUBJ:V_PASS-N---------+                         |              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 51

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  +-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 52

                                                                        +-----------------------------COMP:V-N(by)-----------------------------+              
                     +-------------------COMP:V-N(In)-------------------+            +---------SUBJ:V_PASS-N---------+                         |              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V-N (be,disintegration)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 53

                     +-------------------COMP:V-N(In)-------------------+-----------------------------COMP:V-N(by)-----------------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:V-N(by) (decrease,protein)
COMP:N-N(of) (disintegration,nucleolus)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 54

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |                           +---------------COMP:N-N(by)---------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |                           |                           +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (nucleolus,protein)
SUBJ:V_PASS-N (increase,nucleolus)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 55

                     +-------------------COMP:V-N(In)-------------------+                           +---------------COMP:N-N(by)---------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+                           |                           +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (nucleolus,protein)
SUBJ:V_PASS-N (increase,nucleolus)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 56

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            |                                          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,nucleolus)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 57

                     +-------------------COMP:V-N(In)-------------------+            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            |                                          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+--SUBJ:V_PASS-N-+          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,nucleolus)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 58

                     +-------------------COMP:V-N(In)-------------------+            +-----------------------COMP:N-N(by)----------------------+              
                     +---------COMP:N-N(from)--------+                  |            +---------SUBJ:V_PASS-N---------+                         |              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V-N (be,disintegration)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 59

                     +-------------------COMP:V-N(In)-------------------+                                                                                     
                     +---------COMP:N-N(from)--------+                  |            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+                  |            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
COMP:N-N(from) (lymphocyte,blood)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 60

                                                                                     +-----------------------COMP:N-N(by)----------------------+              
                     +-------------------COMP:V-N(In)-------------------+            +---------SUBJ:V_PASS-N---------+                         |              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V-N--------+     |          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+          |     |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |          |     |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V-N (be,disintegration)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 61

                     +-------------------COMP:V-N(In)-------------------+            +-----------------------COMP:N-N(by)----------------------+              
        +MOD_ATT:N-AD+              +--MOD_ATT:N-ADJ-+--COMP:V-N(from)--+            +---------SUBJ:V_PASS-N---------+          +--MOD_ATT:N-N-+              
        |     +MOD_AT+              |        +MOD_ATT+       +MOD+SUBJ:V+---OBJ:V-N--+-COMP:N-N(of)-+                |          |      +MOD_ATT+              
        |     |      |              |        |       |       |   |      |            |              |                |          |      |       |              
 In activated T lymphocytes from __SP__ peripheral blood , zVAD FMK decreases disintegration of nucleoli that is increased by anti __NODE__ protein antibody .
MOD_ATT:N-ADJ (lymphocyte,activate)
MOD_ATT:N-N (lymphocyte,T)
MOD_ATT:N-ADJ (blood,__SP__)
MOD_ATT:N-ADJ (blood,peripheral)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (decrease,lymphocyte)
COMP:V-N(from) (decrease,blood)
SUBJ:V-N (decrease,FMK)
OBJ:V-N (decrease,disintegration)
COMP:N-N(of) (disintegration,nucleolus)
COMP:N-N(by) (disintegration,protein)
SUBJ:V_PASS-N (increase,disintegration)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__NODE__)